Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 8.3B | 8.9B | 7.4B | 7.6B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | -4.9B | 5.0B | -13.9B | 4.5B |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 2.9B | 3.1B | 1.9B | 2.6B |
Tax provision | 638.8M | 718.6M | 518.4M | 476.8M |
Net income | 2.2B | 2.4B | 1.4B | 2.1B |
Basic EPS | — | 0.1 | 0.1 | 0.1 |
Diluted EPS | — | 0.1 | 0.1 | 0.1 |
Basic average shares | — | 16.6B | 16.7B | 17.0B |
Diluted average shares | — | 16.6B | 16.7B | 17.0B |
EBITDA | — | — | — | — |
Net income from continuing op. | — | — | — | — |
Minority interests | -24.3M | -2.3M | -23.1M | -3.5M |
Preferred stock dividends | 291.6M | 268.5M | 263.8M | 292.8M |